Alpine Global Management’s NxStage Medical Inc. NXTM Stock Holding History

Alpine Global Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-250,000	Closed	-$7.16M	–	268
2018 Q4	$7.16M	Sell	250,000 -24,700	-9%	-$702K	1.82%	9
2018 Q3	$7.66M	Sell	274,700 -40,100	-13%	-$1.13M	1.47%	13
2018 Q2	$8.78M	Sell	314,800 -177,200	-36%	-$4.75M	4.27%	5
2018 Q1	$12.2M	Buy	492,000 +24,411	+5%	+$594K	2.88%	9
2017 Q4	$11.3M	Buy	467,589 +412,403	+747%	+$10.9M	2.58%	8
2017 Q3	$1.52M	Buy	+55,186	New	+$1.47M	0.44%	37

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Alpine Global Management's NXTM Position: Q1 2019 in Review

Alpine Global Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 250,000 shares — an estimated $7.16M sold.

Alpine Global Management first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $12.2M in Q1 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Alpine Global Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Alpine Global Management sold 250,000 NxStage Medical Inc. shares in Q1 2019, an estimated $7.16M.
Alpine Global Management first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Alpine Global Management's NxStage Medical Inc. position peaked at $12.2M in Q1 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Alpine Global Management's 13F filing for Q1 2019, filed 10 May 2019.